Differences between the Molecular Mechanisms Underlying Ruptured and Non-Ruptured Carotid Plaques, and the Significance of ABCA1
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose Carotid plaques are a strong risk factor for ischemic stroke, and plaquerupture poses an even higher risk. Although many studies have investigated the pathogenicmechanisms of carotid plaque formation, few have studied the differences in molecular mechanisms underlying the rupture and non-rupture of carotid plaques. In addition, since early diagnosis and treatment of carotid plaque rupture are critical for the prevention of ischemic stroke, many studies have sought to identify the important target molecules involved in the rupture. However, a target molecule critical in symptomatic ruptured plaques is yet to be identified. Methods A total of 79 carotid plaques were consecutively collected, and microscopically divided into ruptured and non-ruptured groups. Quantitative polymerase chain reaction array, proteomics, and immunohistochemistry were performed to compare the differences in molecular mechanisms between ruptured and non-ruptured plaques. Enzyme-linked immunosorbent assay was used to measure the differences in ATP-binding cassette subfamily A member 1 (ABCA1) levels in the serum. Results The expression of several mRNAs and proteins, including ABCA1, was higher in ruptured plaques than non-ruptured plaques. In contrast, the expression of other proteins, including β-actin, was lower in ruptured plaques than non-ruptured plaques. The increased expression of ABCA1 was consistent across several experiments, ABCA1 was positive only in the serum of patients with symptomatic ruptured plaques. Conclusions This study introduces a plausible molecular mechanism underlying carotid plaquerupture, suggesting that ABCA1 plays a role in symptomatic rupture. Further study of ABCA1 is needed to confirm this hypothesis.
Abstract
Background and Purpose Carotid plaques are a strong risk factor for ischemic stroke, and plaquerupture poses an even higher risk. Although many studies have investigated the pathogenicmechanisms of carotid plaque formation, few have studied the differences in molecular mechanisms underlying the rupture and non-rupture of carotid plaques. In addition, since early diagnosis and treatment of carotid plaque rupture are critical for the prevention of ischemic stroke, many studies have sought to identify the important target molecules involved in the rupture. However, a target molecule critical in symptomatic ruptured plaques is yet to be identified. Methods A total of 79 carotid plaques were consecutively collected, and microscopically divided into ruptured and non-ruptured groups. Quantitative polymerase chain reaction array, proteomics, and immunohistochemistry were performed to compare the differences in molecular mechanisms between ruptured and non-ruptured plaques. Enzyme-linked immunosorbent assay was used to measure the differences in ATP-binding cassette subfamily A member 1 (ABCA1) levels in the serum. Results The expression of several mRNAs and proteins, including ABCA1, was higher in ruptured plaques than non-ruptured plaques. In contrast, the expression of other proteins, including β-actin, was lower in ruptured plaques than non-ruptured plaques. The increased expression of ABCA1 was consistent across several experiments, ABCA1 was positive only in the serum of patients with symptomatic ruptured plaques. Conclusions This study introduces a plausible molecular mechanism underlying carotid plaquerupture, suggesting that ABCA1 plays a role in symptomatic rupture. Further study of ABCA1 is needed to confirm this hypothesis.
참고문헌 (41)
- Mughal MM, "Symptomatic and asymptomatic carotid artery plaque", Expert Rev Cardiovasc Ther, 9, pp.1315~1330 (2011)[DOI]
- North American Symptomatic Carotid Endarterectomy Trial Collaborators, "Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis", N Engl J Med, 325, pp.445~453 (1991)[DOI]
- Executive Committee for the Asymptomatic Carotid Atherosclerosis Study, "Endarterectomy for asymptomatic carotid artery stenosis", JAMA, 273, pp.1421~1428 (1995)[DOI]
- Halliday A, "Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial", Lancet, 363, pp.1491~1502 (2004)[DOI]
- Prabhakaran S, "Carotid plaque surface irregularity predicts ischemic stroke: the northern Manhattan study", Stroke, 37, pp.2696~2701 (2006)[DOI]
- Shah PK, "Mechanisms of plaque vulnerability and rupture", J Am Coll Cardiol, 41(4 Suppl S), pp.15S~22S (2003)[DOI]
- Liu XS, "Comparison of carotid atherosclerotic plaque characteristics by high-resolution black-blood MR imaging between patients with first-time and recurrent acute ischemic stroke", AJNR Am J Neuroradiol, 33, pp.1257~1261 (2012)[DOI]
- Josephson SA, "Evaluation of carotid stenosis using CT angiography in the initial evaluation of stroke and TIA", Neurology, 63, pp.457~460 (2004)[DOI]
- Koenig W, "Biomarkers of atherosclerotic plaque instability and rupture", Arterioscler Thromb Vasc Biol, 27, pp.15~26 (2007)[DOI]
- 허성혁, "Plaque Rupture is a Determinant of Vascular Events in Carotid Artery Atherosclerotic Disease: Involvement of Matrix Metalloproteinases 2 and 9", Journal of Clinical Neurology, 7(2), pp.69~76 (2011), 대한신경과학회
- Dahl TB, "Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization", Circulation, 115, pp.972~980 (2007)[DOI]
- Mannheim D, "Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques", Stroke, 39, pp.1448~1455 (2008)[DOI]
- van der Wal AC, "Atherosclerotic plaque rupture: pathologic basis of plaque stability and instability", Cardiovasc Res, 41, pp.334~344 (1999)[DOI]
- Soumian S, "mRNA expression of genes involved in lipid efflux and matrix degradation in occlusive and ectatic atherosclerotic disease", J Clin Pathol, 58, pp.1255~1260 (2005)[DOI]
- Fernandez-Patron C, "Understanding the mechanism of the zinc-ion stains of biomacromolecules in electrophoresis gels: generalization of the reverse-staining technique", Electrophoresis, 19, pp.2398~2406 (1998)[DOI]
- Fitzgerald ML, "ABC transporters, atherosclerosis and inflammation", Atherosclerosis, 211, pp.361~370 (2010)[DOI]
- Zhu R, "Role of liver X receptors in cholesterol efflux and inflammatory signaling (review)", Mol Med Rep, 5, pp.895~900 (2012)[DOI]
- Brunham LR, "Tissue-specific roles of ABCA1 influence susceptibility to atherosclerosis", Arterioscler Thromb Vasc Biol, 29, pp.548~554 (2009)[DOI]
- Attie AD, "Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis", J Lipid Res, 42, pp.1717~1726 (2001)
- Smith JD, "Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis", Curr Opin Investig Drugs, 11, pp.989~996 (2010)
- Boisvert WA, "ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages", Arterioscler Thromb Vasc Biol, 19, pp.525~530 (1999)[DOI]
- Cuff CA, "The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation", J Clin Invest, 108, pp.1031~1040 (2001)[DOI]
- Kinscherf R, "Characterization of apoptotic macrophages in atheromatous tissue of humans and heritable hyperlipidemic rabbits", Atherosclerosis, 144, pp.33~39 (1999)
- Dekker RJ, "KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium", Blood, 107, pp.4354~4363 (2006)[DOI]
- Das H, "Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes", Proc Natl Acad Sci U S A, 103, pp.6653~6658 (2006)[DOI]
- Son SH, "Perilipin 2 (PLIN2)-deficiency does not increase cholesterol-induced toxicity in macrophages", PLoS One, 7, pp.e33063~ (2012)[DOI]
- Zhao X, "Perilipin1 deficiency in whole body or bone marrow-derived cells attenuates lesions in atherosclerosis-prone mice", PLoS One, 10, pp.e0123738~ (2015)[DOI]
- You SA, "Ferritin in atherosclerosis", Clin Chim Acta, 357, pp.1~16 (2005)[DOI]
- Orino K, "Ferritin and the response to oxidative stress", Biochem J, 357, pp.241~247 (2001)[DOI]
- Gunning PW, "The evolution of compositionally and functionally distinct actin filaments", J Cell Sci, 128, pp.2009~2019 (2015)[DOI]
- Hanukoglu I, "Complementary DNA sequence of a human cytoplasmic actin. Interspecies divergence of 3' non-coding regions", J Mol Biol, 163, pp.673~678 (1983)[DOI]
- Castegna A, "Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71", J Neurochem, 82, pp.1524~1532 (2002)[DOI]
- Lu N, "Oxidative and nitrative modifications of alpha-enolase in cardiac proteins from diabetic rats", Free Radic Biol Med, 48, pp.873~881 (2010)[DOI]
- He Y, "Up-regulated miR-93 contributes to coronary atherosclerosis pathogenesis through targeting ABCA1", Int J Clin Exp Med, 8, pp.674~681 (2015)
- Albrecht C, "ABCA1 expression in carotid atherosclerotic plaques", Stroke, 35, pp.2801~2806 (2004)[DOI]
- Liu HF, "Significance of ABCA1 in human carotid atherosclerotic plaques", Exp Ther Med, 4, pp.297~302 (2012)[DOI]
- Schneiderman J, "Leptin locally synthesized in carotid atherosclerotic plaques could be associated with lesion instability and cerebral emboli", J Am Heart Assoc, 1, pp.e001727~ (2012)
- Kernan WN, "Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association", American Stroke Association, 2014, pp.45, 2160~2236
- Cho KY, "The phenotype of infiltrating macrophages influences arteriosclerotic plaque vulnerability in the carotid artery", J Stroke Cerebrovasc Dis, 22, pp.910~918 (2013)[DOI]
- Darde VM, "Analysis of the plasma proteome associated with acute coronary syndrome: does a permanent protein signature exist in the plasma of ACS patients?", J Proteome Res, 9, pp.4420~4432 (2010)[DOI]
- Spagnoli LG, "Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke", JAMA, 292, pp.1845~1852 (2004)[DOI]